Synutra International

The Company is engaged in the production, distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food, which includes the sale of powdered infant and adult formula products, with brands, including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement, which includes the production and sale of nutritional supplements, such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production, and Other Business, which includes non-core businesses, such as ancillary sales of excess or unusable ingredients and materials to industrial customers; provision of genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women.
Rockville, US
Size (employees)
2,600 (est)
Synutra International is headquartered in Rockville, US

Synutra International Office Locations

Synutra International has an office in Rockville
Rockville, US (HQ)
500 2275 Research Blvd

Synutra International Metrics

Synutra International Financial Metrics

Synutra International's revenue was reported to be $365 m in FY, 2016 which is a 12% decrease from the previous period.

Revenue (FY, 2016)

$365 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

$176.8 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

$21 m

EBIT (FY, 2016)

$46.5 m

Market capitalization (15-May-2017)

$343 m

Closing share price (15-May-2017)


Cash (31-Mar-2016)

$102.7 m


$651.3 m
Synutra International's current market capitalization is $343 m.
FY, 2014FY, 2015FY, 2016


$370.5 m$413.9 m$365 m

Revenue growth, %


Cost of goods sold

$217 m$224.4 m$188.2 m

Gross profit

$153.5 m$189.6 m$176.8 m

Gross profit Margin, %


General and administrative expense

$25.5 m$28 m$27.7 m

Operating expense total

$25.5 m$28 m$27.7 m


$41.6 m$73.7 m$46.5 m

EBIT margin, %


Interest expense

$16.2 m$16 m$16.4 m

Interest income

$4.7 m$7.6 m$8.8 m

Income tax expense

$130 k($4.4 m)$5.5 m

Net Income

$30.3 m$72 m$21 m
FY, 2014FY, 2015FY, 2016


$90.9 m$85.2 m$102.7 m


$84 m$87.8 m$98.4 m

Current Assets

$285.3 m$382.9 m$362 m


$145.8 m$187.1 m$294.2 m

Total Assets

$550.7 m$664.9 m$817.1 m

Accounts Payable

$39.6 m$47.8 m$76.9 m

Total Debt

$252 m$275.1 m$411 m

Current Liabilities

$310.3 m$386.8 m$345.2 m

Additional Paid-in Capital

$135.4 m$135.4 m$134.7 m

Retained Earnings

($104.6 m)($35 m)($14.8 m)

Total Equity

$61.3 m$114.6 m$136.8 m

Debt to Equity Ratio

4.1 x2.4 x3 x

Debt to Assets Ratio

0.5 x0.4 x0.5 x

Financial Leverage

9 x5.8 x6 x
FY, 2014FY, 2015FY, 2016

Net Income

$30.3 m$72 m$21 m

Depreciation and Amortization

$15.4 m$15.2 m$9.5 m

Accounts Receivable

$16 m($380 k)($13.7 m)


($1.2 m)($18.2 m)($24.2 m)

Accounts Payable

($8.7 m)$8.5 m$27.8 m

Cash From Operating Activities

$46.2 m$62.5 m$29.7 m

Purchases of PP&E

($29.6 m)($89.3 m)($103.8 m)

Cash From Investing Activities

($86.7 m)($123.3 m)($102 m)

Long-term Borrowings

($111.9 m)($139.4 m)($149 m)

Cash From Financing Activities

$50.8 m$57.2 m$91.3 m

Interest Paid

$17.3 m
Y, 2016


14 x


22 x


3 x


0.5 x

Financial Leverage

6 x

Synutra International Market Value History

Synutra International Company Life

You may also be interested in